Recruiting

Who we are

  • April 5, 2022
    Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
  • April 5, 2022
    The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
  • April 5, 2022
    A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
  • April 5, 2022
    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
  • April 5, 2022
    Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
  • April 5, 2022
    A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors
  • April 5, 2022
    Partial Liver Segment 2/3 Transplantation Study
  • April 5, 2022
    The Drug Rediscovery Protocol (DRUP Trial)
  • April 5, 2022
    Window of Opportunity Study in Colorectal Cancer
  • April 5, 2022
    Dabrafenib + Trametinib + PDR001 In Colorectal Cancer